Stratec Biomedical Says First-Half Profit Rises 24 Percent to $8 Million

Stratec Biomedical Systems AG said first-half consolidated net income gained 24 percent to 6.1 million euros, as revenue increased.

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.